Physician profile
Daniel Thomas Poole
NPI 1205875234
$12,672.36
in general payments reported to CMS, 2019-2025
80 companies · $2,217 in 2025
The $2,217 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,396 · 2020: $1,291 · 2021: $1,923 · 2022: $1,957 · 2023: $1,848 · 2024: $2,039 · 2025: $2,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,091 · Education: $12.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,091.46 |
| Education | $12.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $888.75 | 2019-2025 | |
| Lundbeck LLC | $750.63 | 2019-2025 | Vyepti, Rexulti |
| Teva Pharmaceuticals USA, INC. | $688.02 | 2020-2024 | Austedo Xr, Austedo |
| Genentech USA, INC. | $673.71 | 2019-2025 | Ocrevus, Xolair, Ocrevus Zunovo |
| Abbvie INC. | $654.53 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $559.76 | 2019-2025 | Ultomiris |
| Ucb, INC. | $515.22 | 2019-2025 | Nayzilam, Briviact |
| Neurocrine Biosciences, INC. | $498.68 | 2019-2025 | Ingrezza, Ongentys |
| Lilly USA, LLC | $455.64 | 2020-2025 | Mounjaro, Zepbound, Amyvid |
| Sk Life Science, INC. | $391.42 | 2020-2025 | |
| Amneal Pharmaceuticals LLC | $341.41 | 2022-2025 | Rytary, Crexont, Ongentys |
| Supernus Pharmaceuticals, INC. | $315.78 | 2019-2022 | |
| Emd Serono, INC. | $301.85 | 2019-2025 | Mavenclad |
| Neurelis, INC. | $286.63 | 2022-2025 | Valtoco |
| Eisai INC. | $282.21 | 2019-2024 |
Show all 80 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $257.60 | 2019-2024 | Recarbrio, Zerbaxa, Dificid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $240.83 | 2019-2025 | Jardiance, Ofev, Tradjenta |
| Aucta Pharmaceuticals, INC. | $238.80 | 2024-2025 | Motpoly Xr |
| Regeneron Healthcare Solutions, INC. | $234.03 | 2019-2025 | Dupixent |
| Amgen INC. | $229.24 | 2019-2023 | Tezspire, Otezla, Repatha |
| Tg Therapeutics, INC. | $217.83 | 2024-2025 | |
| Glaxosmithkline, LLC. | $206.61 | 2019-2025 | Arexvy, Trelegy Ellipta |
| Mdd US Operations, LLC | $199.05 | 2019-2025 | Gocovri, Gocovri |
| Biogen, INC. | $190.65 | 2021-2025 | Tysabri, Vumerity |
| Celgene Corporation | $181.44 | 2021-2025 | Zeposia |
| Impel Pharmaceuticals INC. | $173.78 | 2022-2023 | Trudhesa |
| Novo Nordisk INC | $145.37 | 2020-2025 | Rybelsus, Ozempic |
| Janssen Pharmaceuticals, INC | $141.90 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $139.27 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $137.55 | 2019-2025 | Fasenra |
| Pfizer INC. | $131.80 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $119.58 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $99.75 | 2020-2021 | |
| Amarin Pharma, INC. | $86.76 | 2020-2022 | |
| Recordati_rare_diseases_inc. | $86.21 | 2024-2025 | Isturisa, Signifor Lar |
| Acorda Therapeutics, INC | $84.05 | 2019-2022 | |
| Banner Life Sciences, LLC | $83.86 | 2023-2024 | |
| Avion Pharmaceuticals | $73.38 | 2022-2023 | Dhivy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $72.90 | 2019-2021 | |
| Baxter Healthcare | $71.01 | 2022-2024 | Hillrom - Life 2000 Ventilation System |
| Averitas Pharma INC. | $68.59 | 2024 | Qutenza |
| Argenx US, INC. | $60.19 | 2022-2024 | Vyvgart |
| Avanir Pharmaceuticals, INC. | $59.04 | 2019 | |
| Grifols USA, LLC | $56.17 | 2020-2025 | Prolastin-C Liquid |
| Aprecia Pharmaceuticals, LLC | $48.22 | 2022-2023 | Spritam |
| Abbott Laboratories | $44.31 | 2024-2025 | Freestyle Libre 2, Proclaim |
| Corcept Therapeutics | $43.96 | 2025 | Korlym |
| Kyowa Kirin, INC. | $43.79 | 2022-2023 | Crysvita |
| Genzyme Corporation | $42.71 | 2025 | |
| Vertical Pharmaceuticals, LLC | $40.95 | 2019 | |
| Inspire Medical Systems, INC. | $39.30 | 2025 | Inspire |
| Adamas Pharmaceuticals, INC. | $38.84 | 2019 | |
| Sunovion Pharmaceuticals INC. | $37.30 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $35.40 | 2023-2025 | Rexulti |
| Inogen, INC. | $34.95 | 2022-2025 | |
| Cequr Corporation | $34.28 | 2022-2024 | Cequr Simplicity |
| Advanced Respiratory, INC | $32.91 | 2019-2021 | |
| Axsome Therapeutics, INC. | $32.01 | 2023-2025 | Sunosi, Symbravo |
| Allergan, INC. | $30.95 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $30.05 | 2025 | |
| Dexcom, INC. | $29.48 | 2021-2022 | |
| Verona Pharma, INC. | $28.63 | 2025 | Ohtuvayre |
| Arbor Pharmaceuticals, INC. | $27.07 | 2020-2021 | |
| Beta Bionics, INC. | $25.78 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Insmed, INC. | $23.13 | 2025 | Arikayce |
| Scilex Pharmaceuticals INC. | $21.29 | 2024 | |
| Exact Sciences Corporation | $20.62 | 2023 | Cologuard Collection Kit |
| Almatica Pharma LLC | $18.92 | 2021 | |
| Tanabe Pharma America, INC. | $18.16 | 2021 | |
| Astellas Pharma US INC | $17.05 | 2021 | |
| Bausch Health US, LLC | $16.42 | 2020 | |
| Vivus LLC | $15.78 | 2019 | |
| Mylan Specialty L.P. | $15.35 | 2021 | |
| Philips North America LLC | $15.35 | 2020 | |
| Currax Pharmaceuticals LLC | $14.09 | 2020 | |
| Mannkind Corporation | $13.83 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.75 | 2025 | |
| Harmony Biosciences LLC | $13.15 | 2024 | |
| Biodelivery Sciences International, INC. | $11.78 | 2021 | |
| Livanova USA, INC. | $11.32 | 2020 |
Drugs and devices associated with these payments
Vyepti $583Qulipta $410Ingrezza $362Ubrelvy $355Ultomiris $328Valtoco $270Kesimpta $242Motpoly Xr $239Briumvi $218Mounjaro $213Ongentys $199Rytary $190Zepbound $143Gocovri $129Ocrevus $122Dupixent $118Zeposia $115Tysabri $108Nurtec Odt $107Recarbrio $101Zerbaxa $101Zavzpret $91.80Austedo Xr $90.05Isturisa $86.21Bafiertam $83.86Amyvid $80.36Nayzilam $78.26Ilet Bionic Pancreas $77.34Rybelsus $69.86Ozempic $69.86Crexont $69.79Qutenza $68.59Briviact $68.57Austedo $61.28Vumerity $61.05Jardiance $57.87Dificid $56.04Trudhesa $55.91Hillrom - Life 2000 Ventilation System $51.06Rexulti $48.40Korlym $43.96Prolastin-C Liquid $41.82Xolair $40.89Inspire $39.30Fasenra $36.43Dhivy $35.03Reyvow $32.19Emgality $32.19Arexvy $31.05Trelegy Ellipta $30.46Tzield $30.05Vyvgart $29.49Ohtuvayre $28.63Ocrevus Zunovo $26.15Keytruda $25.81Ilet Insulin Infusion Kit Inset $25.78Ilet Insulin Infusion Kit Contact Detach $25.78Inogen One G5 Oxygen Concentrator - Bluetooth $25.67Ongentys 50mg Capsules 30 $24.90Signifor Lar $24.76Freestyle Libre 2 $23.67Crysvita $23.25Arikayce $23.13Tezspire $22.83Fycompa $21.76Ztlido $21.29Proclaim $20.64Cologuard Collection Kit $20.62Ofev $20.55Mavenclad $20.44Cequr Simplicity $20.41Leqembi $19.67Sunosi $17.46Spritam $16.31Comirnaty $15.63Paxlovid $15.63Otezla $14.72Repatha $14.72Symbravo $14.55Afrezza $13.83Kerendia $13.75Esbriet $13.63Wakix $13.15Tradjenta $13.13Kisunla $11.52Vyalev $8.75
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Poole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.